













This study evaluated dissociative symptomatology, childhood trauma and body uneasiness in 118 individuals with gender dysphoria, also evaluating dissociative symptoms in follow-up assessments after sex reassignment procedures were performed. We used both clinical interviews (Dissociative Disorders Interview Schedule) and self-reported scales (Dissociative Experiences Scale). A dissociative disorder of any kind seemed to be greatly prevalent (29.6%). Moreover, individuals with gender dysphoria had a high prevalence of lifetime major depressive episode (45.8%), suicide attempts (21.2%) and childhood trauma (45.8%), and all these conditions were more frequent in patients who fulfilled diagnostic criteria for any kind of dissociative disorder. Finally, when treated, patients reported lower dissociative symptoms. Results confirmed previous research about distress in gender dysphoria and improved mental health due to sex reassignment procedures. However, it resulted to be difficult to ascertain dissociation in the context of gender dysphoria, because of the similarities between the two conditions and the possible limited application of clinical instruments which do not provide an adequate differential diagnosis. Therefore, because the body uneasiness is common to dissociative experiences and gender dysphoria, the question is whether dissociation is to be seen not as an expression of pathological dissociative experiences but as a genuine feature of gender dysphoria. 
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1.	INTRODUCTION

In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), people whose gender at birth is contrary to the one they identify with are diagnosed with Gender Dysphoria (GD). This diagnosis is a revision of DSM-IV criteria for Gender Identity Disorder (APA, 2000) and is intended to better characterize the experiences and discomfort of GD patients (www.dsm5.org (​http:​/​​/​www.dsm5.org​)). Most of the countries involved in the care of persons with GD have accepted the standards of care (SOC) developed by the World Professional Association for Transgender Health (WPATH) which are based on a somatic and psychiatric assessment before the initiation of a hormone-surgical treatment (Coleman et al., 2012). The psychiatric evaluation consists of verifying the following main criteria: to accurately diagnose the Gender Dysphoria (DSM criteria fulfilled); to verify the persistence of the request; to diagnose/treat any comorbid psychiatric conditions. It is important to note that gender nonconformity is not in itself a mental disorder. The critical element of Gender Dysphoria is the presence of clinically significant distress associated with the condition (Gómez-Gil et al., 2009; Colizzi et al., 2013). In accordance with the WPATH SOC (Coleman et al., 2012), the two major goals of cross-sex hormonal therapy are: 1. to reduce endogenous hormone levels and, thereby, the secondary sex characteristics of the individual’s biological (genetic) sex and assigned gender; and 2. to replace endogenous sex hormone levels with those of the reassigned sex by using the principles of hormone replacement treatment of hypogonadal patients (Hembree at al., 2009). Sex reassignment surgery is often the last and the most considered step in the treatment process for GD. For many patients, relief from GD cannot be achieved without modification of their primary and/or secondary sex characteristics to establish greater congruence with their gender identity (Coleman et al., 2012).
The origins of Gender Dysphoria are still largely unclear (Cohen-Kettenis & Gooren, 1999). Various studies investigated concurrent psychopathology in GD, with contradictory findings. Some research reported a high prevalence of psychiatric comorbidity, including affective disorders, anxiety disorders, substance-related disorders and personality disorders (à Campo et al., 2003; Hepp et al., 2005; Heylens et al., 2013). Moreover, in some cases also a high prevalence of psychotic disorders (à Campo et al., 2003; Hepp et al., 2005), dissociative disorders (à Campo et al., 2003) and somatoform disorders (Hepp et al., 2005) was reported. Instead, other studies indicated that the majority of GD patients had no psychiatric comorbidity (Hoshiai et al., 2010; Gómez-Gil et al., 2012; Fisher et al., 2013; Colizzi et al., 2014). Among these studies showing a low level of psychopathology, affective disorders, anxiety disorders and adjustment disorders were the most common comorbidities (Hoshiai et al., 2010; Gómez-Gil et al., 2012; Fisher et al., 2013; Colizzi et al., 2014).
Attention has been repeatedly drawn in the scientific literature to clinical similarities between GD experiences and dissociative disorders (Coons, 1984; Putnam, 1989; Modestin and Ebner, 1995; Steinberg, 1995). Patients with dissociative identity disorder (DID) frequently experience disturbances in their sexual identity, and many patients with DID have sexually oriented changes in alter-personalities, so that special significance is to be attributed to this disorder with respect to the differential diagnosis of GD. In the last decades a number of case reports of GD patients with features of a DID draw attention to this problem (Lief et al., 1962; Money and Primrose, 1968; Weitzmann et al., 1970; Money, 1974). However, only two studies have recently investigated the occurrence of dissociative symptoms in GD patients by disorder-specific assessment instruments, reporting higher dissociative symptoms than control subjects (Kersting et al., 2003; Shiah et al., 2004). Moreover, in the first study of 41 GD patients who performed a self-reported scale about dissociative symptoms only 6 patients were also evaluated by a clinical interview (Kersting et al., 2003). Instead the second research studied only a small group of 18 Male to Female (MtF) subjects by self-reported evaluations (Shiah et al., 2004).
In the past few decades follow-up studies have shown an undeniable beneficial effect of sex reassignment surgery on GD patients’ subjective well-being. In contrast, the role of the cross-sex hormonal treatment in the well-being of GD patients has been the subject of very little investigation (Murad et al., 2011; Coleman et al., 2012). A meta-analysis identified only five studies that specifically examined the impact of hormonal therapy on GD patients’ well-being, focusing on transformation satisfaction, psychological profile, cognitive function and emotional repercussions (Murad et al., 2011). More recently other studies revealed that hormonal therapy is positively associated with quality of life (Gorin-Lazard et al., 2012; Motmans (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Motmans%20J%5BAuthor%5D&cauthor=true&cauthor_uid=22188877​) et al., 2012) and mental health (Gómez-Gil et al., 2012; Colizzi et al., 2014). Instead, no research has previously investigated the possible effects of hormone therapy as well as sex reassignment surgery on dissociative symptoms in Gender Dysphoria. 
To our knowledge, GD patients’ dissociative disorders comorbidity (qualitative data) and self-reported dissociative symptoms (quantitative data) in the same large sample have not been previously evaluated. Similarly, differences in dissociative symptoms related to hormonal treatment and sex reassignment surgery in a longitudinal study have not been previously reported. 













2.1. Study Design and Sample 
This study incorporated a longitudinal design and was conducted at the Gender Identity Unit of the Bari University Psychiatric Department. A consecutive series of 118 patients was evaluated for Gender Dysphoria from 2008 to 2012. The inclusion/exclusion criteria have been described previously (Colizzi et al., 2014); they were verified during a period of about 24 weeks (enrolment period). The study was proposed to each consecutive eligible subject by the care team during a routine visit. All the 118 individuals (82 MtF; 36 Female to Male, FtM) agreed to voluntarily participate in the study and provided written informed consent.
All the patients in this study received hormonal therapy after the enrollment period. Hormonal treatment for MtF patients consisted of transdermal estradiol gel (1.84 ± 0.49 mg/day), in association with oral cyproterone acetate (100 mg/day). The androgen administration schedule in FTM patients consisted of testosterone administered as intramuscular injections of a testosterone esters depot (250 mg every 26.31 ± 2.68 days). 
While the entire sample of this study received hormone therapy, only 22 subjects (19%) received also sex reassignment surgery [16 MtF (20%), 6 FtM (17%)]. The relatively small numbers of patients who underwent sex reassignment surgery was prevalently due to: 1. limited number of surgical units providing these surgical services at the Bari University. Other less common reasons for not receiving sex reassignment surgery included: 2. specialist medical/psychological report not yet completed (N = 23, 19%); 3. patient’s refusal of surgical treatment (N = 16, 14%); 4. waiting for legal authorization (N = 11, 9%); 5. contraindication to surgery (N = 1, 1%). Of the 16 MtF patients, all individuals received additive mastoplasty while 69% (N = 11) received also vaginoplasty surgery. Of the 6 FtM patients, all individuals received reductive mastoplasty while only 33% (N = 2) received also phalloplasty surgery. 
Only 9 GD patients (8%) [7 MtF (9%) and 2 FtM (6%)] passed in their desired gender role without hormonal treatment; all the other GD patients required hormonal treatment before undertaking gender role reassignment. During the study period all the individuals underwent a “real-life experience”, living full time and continually in the desired gender role, including dressing and interacting socially as the desired gender. The unit has adopted the standards of care guidelines of the WPATH (Coleman et al., 2012). 




2.2.1. Dissociative Disorders Interview Schedule (DDIS)
In order to investigate dissociative disorders in the sample, we used the DDIS schedule. The DDIS is a structured interview consisting of 132 items which investigate dissociative disorders/symptoms, other related conditions, previous/current psychopharmacological treatments, suicide attempts and childhood trauma history (Ross et al., 1989). The DDIS has an overall inter-rater reliability of 0.68 (kappa), a sensitivity of 90% and a specificity of 100% for the diagnosis of dissociative identity disorder (Ross et al., 1989; Saxe et al., 1993). The DDIS was performed during the enrollment period.

2.2.2.	Body Uneasiness Test (BUT)
In order to investigate body image related distress, we used the Body Uneasiness Test (BUT). The BUT is a self-administered questionnaire specifically designed to explore several areas in clinical and non-clinical populations: body shape and/or weight dissatisfaction, avoidance, compulsive control behaviors, feelings of detachment and estrangement toward one’s own body, and specific worries about particular body parts, shapes or functions (Cuzzolaro et al., 2006). The BUT consists of two parts. BUT-A consists of 34 items scored on a six-point Likert-type scale (from 0 to 5); the scores are combined in a Global Severity Index and in 5 subscales: weight phobia, body image concerns, avoidance, compulsive self-monitoring, and depersonalization. BUT-B has 37 items that look at specific worries about particular body parts or functions; the number of items from BUT-B with scores of 1 or higher is summed in a global measure, the Positive Symptoms Total, to indicate overall dislike of body parts. Higher scores indicated greater body uneasiness. The levels of Cronbach’s alpha coefficients range between .64 and .89 (Cuzzolaro et al., 2006), therefore, internal consistency of BUT appears to be good (Thompson et al., 1990). The BUT was performed during the enrollment period.

2.2.3.	Dissociative Experiences Scale (DES)
In order to investigate dissociative symptoms in the sample, we used the DES scale. The Dissociative Experiences Scale (DES) is a 28-item self-report measure of psychological dissociation (Bernstein and Putnam, 1996). It is not a diagnostic tool but serves as a screening device for chronic dissociative disorders, with possible scores ranging from 0 to 100. The instrument has three subscales: amnestic dissociation, depersonalization/derealization and absorption/imaginative involvement. Another subset of 8 DES items forms the taxon subscale, which is thought to be especially sensitive to pathological dissociation (Waller et al., 1996). Waller and colleagues have proposed a procedure to derive Bayesian taxon membership probabilities from these 8 items (Waller and Ross, 1997). These probabilities reflect the chance that individuals belong to the pathological dissociative taxon. Consistently with previous studies (Giesbrecht et al., 2007), we used two different cut-offs to create dichotomous measures of taxon-membership versus nontaxon-membership. Specifically, GD patients with taxon probabilities above 0.50 were assigned to the taxon-50 class (liberal cut-off) and GD patients with a taxon probability exceeding 0.90 were assigned to the taxon-90 class (stringent cut-off). The DES scale has adequate split–half reliability and test–retest reliability, as well as good convergent and dis​criminant validity (Bernstein & Putnam, 1996). The Italian translation (Schimmenti et al, unpublished data) of the DES showed good internal consis​tency, good test–retest reliability, and good convergent validity in a mixed clinical and non-clinical sample. This self-reported questionnaire was performed after the enrollment period, when the GD patients received the eligibility for the cross-sex hormonal treatment (baseline), after about 12 months (53.41 weeks ± 19.13 days) of hormone therapy (HT follow-up), and about 2 years (23.81 months ± 13.18 months) after sex reassignment surgery (SRS follow-up).  
  
2.3.	 Statistical analysis 							
All analyses were conducted using STATA 10 (Stata Corp, USA). The difference of the proportion of MtF and FtM patients among partnership status, living arrangement, employment status, sexual orientation and DDIS dissociative disorder status as well as the difference of the proportion of GD patients with and without a Dissociative Disorder among DDIS dissociative disorder related conditions and childhood trauma history were evaluated using the chi-square (or Fisher’s Exact test for 2 x 2 tables). Also the difference of the proportion of the GD patients and the general population among the DDIS dissociative disorder status was evaluated using the chi-square. The comparison of age and level of education between MtF and FtM patients as well as the comparison of DES scores, DDIS features associated with Dissociative Identity Disorder and BUT body image related distress between GD patients with and without a Dissociative Disorder were performed using independent t-tests. Also the comparison of DES scores between GD patients and the general population was performed using independent t-test. The comparison of DES scores between untreated (baseline) and treated GD patients (HT and SRS follow-up) was performed using dependent/independent t-tests and McNemar’s tests. Finally, GD patients’ DES scores were also calculated excluding the item on the gender related sense of strangeness, as in Kersting et al., 2003. The obtained baseline GD patients’ DES scores were compared to the general population’s DES scores using independent t-tests. The significance level was set at p <0.05. 
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3.1. Sociodemographic information 
Age, level of education, partnership status, living arrangement, employment status and sexual orientation of the 118 GD patients included in this study were reported in Table 1. MtF and FtM did not show differences between their sociodemographic characteristics (Table 1; all p > 0.1). There were no differences in sociodemographic characteristics between GD patients who received only hormonal treatment (n = 96) and GD patients who received also sex reassignment surgery (n = 22; all p > 0.1).     

3.2.	Prevalence of Dissociative Disorders
The lifetime prevalence of dissociative disorders among GD patients was 29.6% (n=35). Dissociative disorder not otherwise specified (DDNOS) was the most prevalent type of dissociative disorder. Instead, DID, the most complex dissociative disorder, was relatively rare (Table 2). There were no significant differences in sociodemographic variables between GD patients with and without a dissociative disorder (all p > 0.1). Moreover, there were no significant differences in the lifetime prevalence of dissociative disorders between MtF and FtM patients (all p > 0.1; Table 2). Finally, the DDIS dissociative disorder rate in GD individuals was higher than that obtained among a general population (n = 502) with the same methodology (12.2%; χ2 = 22.4, p < .001) by Ross (1991).

3.3.	Dissociative disorder related conditions, childhood trauma history and body image related distress 
Of the 118 GD patients included in this study, 54 individuals (45.8%) received a lifetime major depressive episode diagnosis based on the DDIS interview.  Somatization disorder was the most common dissociative disorder related condition (17.8%). Instead, substance abuse was relatively rare (1.7%). More than one out of five patients reported suicide attempts (21.2%, n= 25). In addition, 31 patients (26.3%) reported a previous psychopharmacological treatment. Instead, only 17 patients (14.4 %) reported a current psychopharmacological treatment (Table 3). Except for substance abuse, the prevalence of these conditions among the group with a dissociative disorder was significantly higher than for the remaining research participants (Table 3).
Furthermore, a large part of the GD group reported childhood trauma (abuse and/or neglect, 45.8%). Physical and emotional neglect had the highest average prevalence, followed by emotional and physical abuse (Table 4). Except for nutrition and medical care, participants with a dissociative disorder reported all types of childhood trauma more frequently than the remaining GD patients (Table 4).
Finally, participants with a dissociative disorder reported higher scores for all the DDIS features associated with dissociative identity disorder, compared with participants with no history of dissociative disorder (DID; Table 5). Similarly, GD patients with a dissociative disorder reported higher body image related distress for all the BUT areas, with the exception of the compulsive self-monitoring, which only tended to be significantly higher (Table 5).

3.4.	Dissociative symptoms scores in GD patients according to the dissociative disorder status and before (baseline) and after sex reassignment procedures (cross-sex hormonal treatment and sex reassignment surgery follow-up)    
Participants with a dissociative disorder reported significantly higher scores for the DES total and subscales scores compared to the remaining GD patients (Table 5). Moreover, the prevalence of DES dissociative symptoms at baseline (n = 118, M = 13.54, SD = 10.78) was significantly higher than that found in a general population with the same methodology (n = 1055, M = 10.8, SD = 10.2; t = 2.75, p = .006) by Ross and colleagues (1990). However, considering the prevalence of pathological dissociation, based on the DES taxon subscale and related taxon membership probabilities, a relatively low proportion of GD patients reported a score symptomatic of pathological dissociation (> 0.50; 11%, N = 13). The prevalence of pathological dissociation was even lower applying a stringent cut-off (> 0.90; 5%, N = 6; Table 6). 
When treated with cross-sex hormonal treatment (HT follow-up) GD patients reported significant lower depersonalization/derealization (p < .001), absorption/imaginative involvement (p = .027) and DES total score (p < .001) than at baseline (Table 6). Even if the DES taxon score was significantly lower in hormone treated GD individuals (p = .04), cross-sex hormonal treatment did not significantly reduce the proportion of individuals with a taxon membership probability symptomatic of pathological dissociation (all p > 0.1, Table 6). A similar pattern was found in GD patients after sex reassignment surgery: at SRS follow-up, GD patients reported significant lower depersonalization/derealization (p = 0.001) and DES total score (p = 0.048) than at baseline (Table 6), while DES taxon score and taxon membership probabilities were not influenced by sex reassignment surgery (all p > 0.1). Instead, there were no significant differences in GD patients’ DES scores between HT and SRS follow-up. Moreover, the prevalence of DES dissociative symptoms at HT follow-up (n = 118, M = 8.70, SD = 9.47) was significantly lower than that found in the general population (Ross et al., 1990; t = 2.14, p = .03). Instead, the prevalence of DES dissociative symptoms at SRS follow-up (n = 22, M = 8.87, SD = 5.02) was not significantly different from that found in the general population (Ross et al., 1990; t = 0.88, p = .38). 









This study reported for the first time a large and systematic investigation of the prevalence of dissociative disorders, dissociative disorder related conditions, childhood trauma history and body image related distress in Gender Dysphoria, also investigating the role of cross-sex hormonal treatment as well as sex reassignment surgery in GD patients’ dissociative symptoms. Although a previous evaluation in the same sample did not indicate a high prevalence of current major psychiatric disorders (14.4%) based on SCID-I interviews (Colizzi et al., 2014), nearly one out of three patients fulfills diagnostic criteria for a dissociative disorder (29.6%) based on DDIS interviews. The DDIS dissociative disorder rates as well as the prevalence of DES dissociative symptoms at baseline are higher than that obtained among a general population with the same clinical assessments (Ross et al., 1990; Ross, 1991). Moreover, GD patients have a high prevalence of lifetime major depressive episode (45.8%), suicide attempts (21.2%) and childhood trauma (abuse and/or neglect, 45.8%). In addition, compared to the group without a dissociative disorder, patients with a dissociative disorder report more frequent dissociative symptoms, lifetime major depressive disorder, somatization disorder, previous/current psychiatric treatment, suicide attempts, childhood trauma and body image related distress. This result seems to suggest that individuals with increased psychosocial distress are more prone to express dissociative symptoms in the context of their GD. These findings are similar to those of other studies that have documented a wide overlap among conversion disorder and dissociative disorders and among childhood trauma, dysthymic disorder, major depression, and somatization disorder (Saxe et al., 1994; Hudziak et al., 1996; Şar et al., 2004; 2007). Moreover, our results extend previous findings on body related distress in GD patients (Fisher et al., 2014), indicating that dissociative disorder comorbidity is associated to increased body uneasiness among GD patients. Finally, the prospective study indicates that sex reassignment procedures are associated with reduced dissociative symptoms. 
Dissociative disorder not otherwise specified (DDNOS) is the most frequent dissociative diagnosis in the present study (16.1%), consistently with previous observations in clinical settings (Ross et al., 1991; Şar et al., 2000), non-clinical samples (Şar et al., 2007) and GD patients (Kersting et al., 2003). However, because NOS disorders in DSM-IV should be atypical and uncommon, the large number of DDNOS diagnoses in the present study points to a major weakness of the DSM-IV diagnostic criteria. The elevated prevalence of DDNOS diagnosis in this study was based primarily on the answering of those items concerning the sense of living in a different body or feeling disconnected from parts of their body and insecurity with respect to identity. In fact, DDNOS include one or more personality states bearing the concept of having a body differing from the biological gender. In individual cases the DDNOS symptoms and GD may be similarly expressed, making the differential diagnosis more difficult. Instead, in DID the disturbance of the gender identity is expressed in a global manner, rather than just gender (Putnam, 1989). Consistently, except for one patient, no further relevant dissociative symptoms were recorded that would justify the diagnosis of a DID. Interestingly enough, considering only DDIS DID diagnosis (n = 1, 0.8%), the prevalence of the most complex form of dissociative disorder overlaps with that found in our previous study which detected only one case of DID using the SCID-I (Colizzi et al., 2014). It should be added that calculating the baseline DES total score without the item on the gender related sense of strangeness the prevalence of dissociative symptoms among GD individuals is definitely lower, consistently with the previous study by Kersting and colleagues (2003). Moreover, the DES total score without this item is only slightly increased and not significantly different compared to the general population (Ross et al., 1990). In summary, because the unease with the biological sex and the aversion to the corresponding sex-specific body forms belong by definition to the GD diagnosis (APA, 2000), the question arising is whether the dissociation is to be seen in this case not as an expression of a pathological dissociative experience but rather as a genuine feature of the GD. This interpretation is supported by several findings: first, the dissociative experience was less intense in GD patients after the beginning of the hormonal treatment and remained steadily lower after sex reassignment surgery; second, applying the DES taxon subscale stringent cut-off, the prevalence of pathological dissociation was relatively rare and not reduced by hormone therapy, suggesting that only a small proportion of GD patients really suffers from pathological dissociation (N = 6, 5%). Anyway, the application of additional and/or exclusion criteria could lead to a more precise ascertainment of the wish for a change of sex to differentiate whether it is a genuine expression of GD or whether there are indications of heterosexual self-states that merely resemble the GD.  
As DID, the most extensively studied syndrome within the spectrum of dissociative disorders, has been conceptualized as a complex posttraumatic disorder resulting from severe childhood abuse (Putnam, 1991; Ross, 1997), the high prevalence of traumatic experiences during childhood in the GD patients (45.8%) is very interesting, especially when considering the subgroup which fulfills a DDIS dissociative disorder diagnosis (71.4%). These findings suggest that abuse and neglect during childhood could have a role in dissociative disorders as well as in the development of gender identity. Consistently, previous studies have shown high rates of childhood sexual, emotional, and physical abuse among transsexuals (Pauly, 1974; Lothstein, 1983; Devor, 1994; Kersting et al., 2003; Gehring & Knudson, 2005), although these studies did not use control groups. Only two controlled studies have indicated an association between a less warm, more emotionally distant, controlling or rejecting parent and gender-variant outcomes (Parker and Barr, 1982; Cohen-Kettenis and Arrindell, 1990). The effects of severe childhood traumatization on gender identity need to be further investigated.
Results of this longitudinal study underline the suffering of non-treated GD patients and the probable favorable evolution of their dissociative symptoms after sex reassignment procedures. Previous studies reported a higher prevalence of dissociative disorders/symptoms in the female gender, both in clinical (Şar et al., 2000) and non-clinical samples (Şar et al., 2007). Moreover, estrogens and androgens may plausibly exert opposite and/or prevalently negative effects on mental health. Estrogens may make individuals more prone to anxiety and depression (Asscheman (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=Asscheman%20H%5BAuthor%5D&cauthor=true&cauthor_uid=2528051​) et al., 1989). Androgens would promote feelings of euphoria and energy (Su et al., 1993) or stress and hostility (King (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed?term=King%20JA%5BAuthor%5D&cauthor=true&cauthor_uid=16136009​) et al., 2005). Hence, one would expect to find a higher prevalence of dissociative disorders/symptoms in FtM patients than in MtF patients at enrollment and the opposite condition or a worsening in both groups due to hormonal treatment. Nevertheless, despite the limited sample power when considering the two groups separately, our study indicates that hormonal treatment reduces dissociative symptoms both in MtF and FtM patients. Therefore, as previously reported by Kuiper and Cohen-Kettenis, our results could not support the hypothesis of a direct relation between the hormone therapy itself and the patients’ subjective well-being (1988). GD patients face major stress in managing their gender identity (Colizzi et al., 2013) and dissociative symptoms may be considered as a reaction to the non-satisfaction connected to their incongruent image. Instead, hormone therapy induces desired changes in GD patients’ body features and shape and this could translate into a better quality of life for the patient himself. In fact, thanks to the body changes obtained, GD patients have been reported to experience a reduction of self-reported distress (Gómez-Gil et al., 2012; Colizzi et al., 2013). Therefore, the change in gender role among all the hormone treated GD patients included in this study should probably influence the self-reported reduced dissociative symptoms. However, the few patients who passed in their desired gender role without hormonal treatment did not show a lower prevalence of dissociative symptoms than all the other patients, both at baseline and follow-up, suggesting that the sex reassignment procedures may reinforce the gender affirmation with a better social recognition. Moreover, the initiation of the hormonal treatment could have a psychological meaning which per se could be fundamental in reducing distress. Future studies should more precisely examine the hormones role in the life of GD patients. Understanding these mechanisms is extremely important if one wants to grant early enough interventions to GD patients who seem to live a very distressful condition. 
It could be of interest to study dissociative symptoms according to the sexual orientation, as gynephilic sexual orientation has been suggested to be quite prevalent among MtF patients (Blanchard, 1985) and also associated with increased mental distress and a different pattern of body dysphoria (Lawrence, 2010). However, in contrast to Blanchard’s initial findings, we found a low proportion of MtF patients gynephilic (n = 6, 7%). As suggested by Nieder and colleagues (2011), some MtF patients could believe that they are not eligible for gender reassignment if they report being attracted to females. Anyway, we did not find any significant difference in the MtF patients’ dissociative symptoms according to their sexual orientation, even if data are too limited to express conclusively. 
This study has some limitations that should be taken into account. The generalization of our results may be limited by the fact that, due to the substantial overlapping between DDNOS and GD manifestations (Kersting et al., 2003), the DDIS interview could not represent an appropriate instrument to ascertain dissociative disorders in GD individuals. Moreover, even if GD patients’ dissociative symptoms/disorders were compared with data representative of the general population (Ross et al., 1990; Ross, 1991), our sample and the normative data were not matched for age, which might affect the average values of dissociation (Ross et al., 1990). Finally, our care pathway provides continuous psychological support to GD patients’ emotional and behavioural changes that occur during the hormonal treatment. When necessary our care pathway also provides psychopharmacological treatment in order to treat and stabilize any psychiatric comorbidity before the beginning of hormone therapy (14.4% of this sample), in accordance with WPATH standards of care (Coleman et al., 2012). Finally, our clinical experience suggests that, when receiving eligibility for hormonal treatment, GD patients experience a distress reduction because of their understood discomfort. We cannot exclude a positive effect of psychological treatment and healthcare on dissociative symptoms reduction. Therefore, psychological and medical health support could partially explain our findings. We suspect that findings would likely be different if therapies were discontinued or in patients who have no possibility of being attended by a gender unit and/or of exploring their expectations with healthcare professionals.
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